Table 2 Parameters used for the evaluation of the effects on patients’ outcome
From: Robot-assisted early mobilization of intensive care patients: a feasibility study protocol
Clinical examination | ||
 Strength level of upper and lower extremities at last physical examination using Medical Research Council classification (scale: 0–5) | ||
Sonographic examination | ||
 Diaphragm | M. quadriceps femoris | |
Personal data | ||
 Age (years) | Sex (m/f/d) | Height (cm) |
 Weight (kg) | Diagnosis | Chronic conditions |
Laboratory values from clinical routine in last 24h | ||
Medication | ||
 Sufentanil (μg/d) | Insulin bolus + infusion (IU) | |
 Piritramide (mg/d) | Naloxone (mg/d) | |
 Midazolam (mg) | Sodium picosulfate (mg/d) | |
 Dexmedetomidin (μg/d) | Neostigmine (mg/d) | |
 Propofol (mg/d) | Macrogol 3350 (units/d) | |
Clinical data | ||
 SOFA score | Operative status | |
 APACHE II score | Min. Horovitz index (mmHg) | |
 SAPS II score | max. PEEP (mbar) | |
 RASS score | max. Pinsp (mbar) | |
 VAS score | max. respiratory rate (x/min) | |
 GCS score | Data organ replacement (yes/no) | |
 Temperature (°C) | ECMO therapy (yes/no) | |
 Mean arterial pressure (mmHg) | Duration of invasive ventilation since admission (hours) | |
 Heart rate (bpm) | Duration of non-invasive ventilation since admission (hours) | |
 Cardiac index (L/min) | Duration of invasive ventilation since admission (0.0–1000.0) | |
 Bicarbonate (mmol/L) | Export urine (mL) | |
 Blood pH | AKIN stadium | |
 Lactate (mmol/L) |  | |
 Amount of reflux (mL) |  | |
 Bowel movement (active/sluggish /none) |  | |
 Amount of stool (frequent/average/little) |  | |